Etanercept-related extensive pulmonary nodulosis in a patient with rheumatoid arthritis

J Rheumatol. 2007 Jul;34(7):1590-2. Epub 2007 Jun 15.

Abstract

Although nodulosis is a common extraarticular manifestation of rheumatoid arthritis, accelerated pulmonary nodulosis is a rare event. The etiology of rheumatoid nodules is still unknown. Nodulosis is not necessarily associated with active joint inflammation, suggesting different pathogenic mechanisms for nodule formation and synovial tissue inflammation. We describe a patient with extensive pulmonary nodulosis, probably related to etanercept treatment. Our case emphasizes the need for careful monitoring for adverse events during treatment with biologicals, especially since the differential diagnosis often includes a broad spectrum of diseases.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid*
  • Azathioprine / therapeutic use
  • Drug Therapy, Combination
  • Etanercept
  • Humans
  • Immunoglobulin G / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Male
  • Middle Aged
  • Prednisone
  • Radiography, Thoracic
  • Receptors, Tumor Necrosis Factor
  • Rheumatoid Nodule / chemically induced*
  • Rheumatoid Nodule / drug therapy
  • Rheumatoid Nodule / pathology
  • Tomography, X-Ray Computed
  • Withholding Treatment

Substances

  • Anti-Inflammatory Agents
  • Antirheumatic Agents
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Azathioprine
  • Etanercept
  • Prednisone